- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03951168
Health Education for Diabetes Mellitus (hefdm)
Study on Standardized Management Model of Health Education for Diabetes Mellitus
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim was to develop a standardized patient education model reflecting the core educational elements recommended by Chinese diabetes society guideline, which could be delivered by nurses to hospitalized diabetes patients, and which could be easily scaled-up and implemented in China tier 3 hospital setting.
Management mode of standardized diabetes mellitus health education in intervention group.The control group carries on the routine diabetes mellitus health education management. In intervention group , All participants received Management mode of standardized diabetes mellitus health education.The standardized patient education included one-week personalized education on diabetes knowledge, diet and excise, glucose monitoring and hypoglycemia self-management and others during the hospitalization period. After discharge, patients were followed through the phone call at 2and 4 weeks. Follow-up of diabetic education outpatients at 12 and 24 weeks after discharge. The education nurse gave recommendations according to patent's problem during the follow-up. Full-time education nurses carry on education according to diabetes mellitus health education path table. In routine, After hospitalization, the responsible nurses interspersed with diabetes health education during the hospitalization. The health education is mainly about the problems observed by the responsible nurses and the problems raised by the patients. The patients were followed up by telephone 2 weeks after discharge.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710061
- First Affiliated Hospital of Xi'an Jiaotong University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Type 2 diabetes patients with World Health Organization(WHO) diagnosis (1999);
- HbA1c ≥ 7.5%;
- history of diabetes < 2 years;
- age from 18 to 70 years;
- having the ability of autonomous behavior, informed consent and voluntary participation in the study.
Exclusion Criteria:
- type 1 diabetes mellitus, gestational diabetes mellitus and other special types of diabetes;
- severe acute and chronic diseases, severe psychological failure, lung failure, tumor, etc.
- is participating in other researchers.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Routine Management
The patients were divided into routine diabetic health education management model group.
Patients who meet the criteria for admission and discharge.
|
Routine Management Model of Health Education for diabetes Patient will receive the Routine Management Model of Health Education for Diabetes.
After the patient was admitted to hospital, the responsible nurse carried on the diabetes health education for the patient.
There are no regulations on the path and time of education.
Interspersed with diabetes health education at work.
Follow up 2 weeks with phone call after discharge.
This is the current clinical model in hospital.
|
Experimental: Standardized Management
The patients were divided into standardized diabetes health education management model group.
Patients who meet the criteria for admission and discharge.
|
Standardized Management Model of Health Education for Diabetes The patients were educated by full-time diabetic education nurses according to diabetes education path.
Including diabetes diet, exercise, drugs, hypoglycemia, diabetic foot, and so on.
Telephone follow-up was performed at 2 weeks and 4 weeks after discharge and 12 and 24 weeks follow-up in diabetes education clinic.
Develop telephone follow-up standardized content and implement telephone follow-up according to standardized content.Full-time education nurses carry on education according to diabetes mellitus health education path table.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diabetes knowledge questionnaire ( DKQ)
Time Frame: after 6 months
|
The DKQ was translated from English into Chinese by a native bilingual translation specialist and then back translated by a different native bilingual speaker and checked for accuracy, clarity and content equivalence by conducting forward and back translations to verify translation equivalence. DKQ was translated from English into Chinese by a native bilingual translation specialist and then back translated by a different native bilingual speaker and checked for accuracy,clarity and content equivalence by conducting forward and back translations to verify translation equivalence. |
after 6 months
|
Summary of Diabetes Self-Care Activities-6 (SDSCA-6)
Time Frame: after 6 months
|
Evaluation the patient self management skill
|
after 6 months
|
Diabetes empowerment Scale-Diabetes Attitudes Wishes & Needs Short Form (DES-DSF)
Time Frame: after 6 months
|
Evaluation the patient empowerment
|
after 6 months
|
Diabetes Specific Quality of Life
Time Frame: after 6 months
|
Evaluation the patient quality of life
|
after 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HbA1c
Time Frame: after 6 months
|
the patient'S blood glucose level
|
after 6 months
|
Fasting glucose
Time Frame: after 6 months
|
the patient'S blood glucose level
|
after 6 months
|
2h postprandial glucose
Time Frame: after 6 months
|
the patient'S blood glucose level
|
after 6 months
|
blood pressure
Time Frame: after 6 months
|
the patient 'S blood pressure
|
after 6 months
|
Total Cholesterol
Time Frame: after 6 months
|
the patient'S Total Cholesterol
|
after 6 months
|
LDL-C
Time Frame: after 6 months
|
he patient'S LDL-C
|
after 6 months
|
HDL-C
Time Frame: after 6 months
|
he patient'S HDL-C
|
after 6 months
|
Collaborators and Investigators
Investigators
- Study Chair: Meng Li, First Affiliated Hospital of Xi'an JiaoTong Univerisity
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018KRM115
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Joslin Diabetes CenterCambridge Medical Technologies, LLCCompletedType 2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Routine Management
-
Peking University First HospitalRecruitingProtocol-based Management and Perioperative Outcomes in Patients With Chronic Antithrombotic TherapyPerioperative Care | Antithrombotic Therapy | Perioperative OutcomesChina
-
Assistance Publique Hopitaux De MarseilleNot yet recruitingHirschsprung's DiseaseFrance
-
Assiut UniversityNot yet recruitingAluminium Phosphide Poisoning
-
Research Center BorstelLudwig-Maximilians - University of Munich; "Marius Nasta" Pulmonology InstituteCompleted
-
Shanghai Yueyang Integrated Medicine HospitalRecruitingColorectal CancerChina
-
University of TurkuSuspendedDiabetes Mellitus, Type 2China
-
Rambam Health Care CampusWithdrawn
-
Teesside UniversityCompleted
-
Changhai HospitalRecruitingCardiovascular Diseases | Vascular Diseases | Stroke | Cerebrovascular Disorders | Brain Diseases | Central Nervous System Diseases | Nervous System DiseasesChina
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingAcute Myocardial InfarctionChina